Introduction
Initial arrest of premature labor may be successfully achieved by a variety of tocolytic agents. At present beta-adrenergic agonists are the most useful clinical agents to prevent or reduce uterine activity [6] , Beta-adrenergic stimulation decreases frequency and intensity of uterine contractions. In the past few years, successful labelling of receptors by radiolabelled agonists or antagonists has enabled the study of beta-adrenoreceptors in many tissues from several mammalian species. It has recently been shown that the beta-adrenergic ligand [ 3 H]-dihydroalprenolol (DHA) is able to label binding sites in human term placenta [7] and myometrium [5] , We have previously demonstrated betaadrenergic receptors in early human placenta [3] . The binding properties of beta-adrenoreceptors allow a first evaluation of the pharmacological properties of the ligand under study. The data reported herein represent the displacement of [ 3 H]-DHA binding from human myometrial and placental membranes by tocolytic agents which are used in clinical practice or could be used in the future.
Materials and methods
Human myometrial strips were obtained from uteri at the time of cesarean section. Term [3] . The tissues were homogeniz-drugs were determined by linear regression as ed in 10 volume of buffer containing 10 mM the X intercept on a HILL plot which was deterTris. HC1 0.25 M sucrose, 1 mM EDTA and mined by least square method. Ki values were 3mM MgCk, pH 7.4, using an Ultra-Turrax determined by the equation of CHENG and PRUhomogenizer. The homogenate was passed SOFF [2] . through four layers of gauze and centrifuged at 600 χ g for 10 min at 4 °C to remove unbroken _ IC 50 cells and connective tissue. The supernatant ' ~~ S/K m + 1 was centrifuged twice at 48 000 χ g for 20 min, with washing of the intermediate pellet. The where ICso is the concentration of the competfmal pellet was resuspended in assay buffer j ng agent which inhibits curves with apparent HILL coefficients (nH) significantly higher than unity (p < 0.01) indicating heterogenity of binding (positive cooperativity). In general, binding of beta-adrenoreceptor agonists was weaker in myometrium than in placenta homogenates.
Conclusions
In this study we compared the binding of various tocolytic agents to beta-adrenoreceptors in homogenates from human placenta and myometrium.
In a previous investigation [4] we observed that the density of beta-adrenergic receptors in the placenta is much higher than in the myometrium. According to these results we believe that the betamimetic agents may dilate the vascular vessels in the placenta during the treatment of premature labor. This may result in rising of blood-flow and increasing secretion of progesterone as suggested by CARITIS and ZELEZNIK [1] , So it is very likely that the placenta may play an important role in the pharmacological mechanisms of tocolytic agents in inhibitory preterm myometrial activity. Although there is low binding capacity of beta-adrenergic receptors in human pregnant myometrium one has to reckon with a direct effect of tocolytic agents on myometrium.
In our earlier studies [3] the epinephrine, norepinephrine and isoproterenol displacement of [ 3 H]-DHA in placenta membranes were shallow yielding a HILL coefficient of 0.43-0.53. The present results show that tocolytic agents give higher HILL coefficients than unity. This discrepancy could be explained by positive cooperativity which is peculiar to the tested drugs. Further investigation is needed to complete understanding of this phenomenon.
A major point of this paper has been to examine the binding properties of clenbuterol. In accordance with pharmacological experiments which proved the substance to be a potent betaadrenoreceptor agonist, clenbuterol binds to human myometrial and placental beta-adrenoreceptors with high potency.
